... treated with primary combined androgen blockade followed by second-line antiandrogen therapy at prostate-specific antigen (PSA) relapse. The cause-specific survival after second-line therapy was compared according to various clinical factors. Results: Of the several variables isolated as prognostic...

... cells showed a biphasic hypersensitive response to androgenic stimulation. Passages later than 75 are inhibited by androgen. Proliferation of LNCaP-abl cells was stimulated by the pure nonsteroidal antiandrogen bicalutamide (Casodex). To improve our understanding of changes which occur during...